Northwest Biotherapeutics OTC Stock Forecast - Daily Balance Of Power
| NWBO Stock | USD 0.28 0.01 3.70% |
Northwest OTC Stock Forecast is based on your current time horizon.
Northwest |
| Check Northwest Biotherapeutics Volatility | Backtest Northwest Biotherapeutics | Trend Details |
Northwest Biotherapeutics Trading Date Momentum
| On December 03 2024 Northwest Biotherapeutics was traded for 0.28 at the closing time. The top price for the day was 0.28 and the lowest listed price was 0.27 . The trading volume for the day was 839.6 K. The trading history from December 3, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 3.70% . The trading delta at closing time against the current closing price is 3.70% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Northwest Biotherapeutics to competition |
Other Forecasting Options for Northwest Biotherapeutics
For every potential investor in Northwest, whether a beginner or expert, Northwest Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Northwest OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Northwest. Basic forecasting techniques help filter out the noise by identifying Northwest Biotherapeutics' price trends.Northwest Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Northwest Biotherapeutics otc stock to make a market-neutral strategy. Peer analysis of Northwest Biotherapeutics could also be used in its relative valuation, which is a method of valuing Northwest Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Northwest Biotherapeutics Technical and Predictive Analytics
The otc stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Northwest Biotherapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Northwest Biotherapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Northwest Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Northwest Biotherapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Northwest Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Northwest Biotherapeutics otc stock market strength indicators, traders can identify Northwest Biotherapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 93249.7 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 0.29 | |||
| Day Typical Price | 0.28 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 42.81 |
Northwest Biotherapeutics Risk Indicators
The analysis of Northwest Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Northwest Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting northwest otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.57 | |||
| Standard Deviation | 3.85 | |||
| Variance | 14.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Northwest Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Northwest Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northwest Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Northwest OTC Stock
| 0.76 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.63 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.54 | VANI | Vivani Medical | PairCorr |
| 0.46 | VCYT | Veracyte | PairCorr |
| 0.38 | VAXX | Vaxxinity | PairCorr |
The ability to find closely correlated positions to Northwest Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Northwest Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Northwest Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Northwest Biotherapeutics to buy it.
The correlation of Northwest Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Northwest Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Northwest Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Northwest Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Northwest OTC Stock
Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.